SBRA:NGS-Sabra Healthcare REIT Inc. (USD)

EQUITY | REIT - Healthcare Facilities | Nasdaq Global Select

Last Closing

USD 13.94

Change

0.00 (0.00)%

Market Cap

USD 1.42B

Volume

1.64M

Analyst Target

USD 14.65
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Sabra Health Care REIT Inc operates as a self-administered & self-managed REIT. The Company through its subsidiaries is engaged in acquiring, financing and owning real estate property to be leased to third party tenants in the healthcare sector.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-28 )

Largest Industry Peers for REIT - Healthcare Facilities

Symbol Name Price(Change) Market Cap
DHC Diversified Healthcare Trust

-0.22 (-8.46%)

USD 0.55B
HTIA Healthcare Trust Inc PR

+0.21 (+1.45%)

N/A
HTIBP Healthcare Trust Inc Preferred..

-0.21 (-1.50%)

N/A

ETFs Containing SBRA

JRE Janus Henderson U.S. Real.. 4.92 % 0.00 %

+0.21 (+0.58%)

USD 3.25M
KBWY Invesco KBW Premium Yield.. 3.91 % 0.35 %

+0.05 (+0.58%)

USD 0.20B
SRET Global X SuperDividend® .. 3.63 % 0.59 %

+0.06 (+0.58%)

USD 0.21B
GRI GRI Bio Inc. 0.00 % 0.55 %

N/A

USD 0.75M
XMMD:LSE Xtrackers - MSCI Emerging.. 0.00 % 0.00 %

+0.58 (+0.58%)

USD 0.67B
SDIV:LSE Global X SuperDividend UC.. 0.00 % 0.00 %

+0.06 (+0.58%)

USD 0.09B

Market Performance

  Market Performance vs. Industry/Classification (REIT - Healthcare Facilities) Market Performance vs. Exchange (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -2.31% 100% F 49% F
Dividend Return 2.10% 50% F 83% B
Total Return -0.21% 100% F 53% F
Trailing 12 Months  
Capital Gain 22.28% 75% C 78% C+
Dividend Return 10.53% 100% F 94% A
Total Return 32.81% 75% C 82% B
Trailing 5 Years  
Capital Gain -28.73% 100% F 37% F
Dividend Return 33.74% 100% F 93% A
Total Return 5.01% 100% F 52% F
Average Annual (5 Year Horizon)  
Capital Gain -6.51% 50% F 31% F
Dividend Return 1.54% 75% C 46% F
Total Return 8.05% 100% F 95% A
Risk Return Profile  
Volatility (Standard Deviation) 25.45% 50% F 69% C-
Risk Adjusted Return 6.06% 75% C 46% F
Market Capitalization 1.42B 100% F 85% B

Key Financial Ratios

  Ratio vs. Industry/Classification (REIT - Healthcare Facilities) Ratio vs. Market (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 22.80 50% 5%
Price/Book Ratio 1.14 50% 65%
Price / Cash Flow Ratio 10.72 100% 24%
Price/Free Cash Flow Ratio 17.82 50% 14%
Management Effectiveness  
Return on Equity 0.47% 100% 59%
Return on Invested Capital 4.32% 75% 67%
Return on Assets 2.45% 100% 77%
Debt to Equity Ratio 82.77% 100% 29%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Underpriced on cashflow basis

The stock is trading low compared to its peers on a price to cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.